Dominique Monnet
Director/Board Member chez PDL BIOPHARMA, INC.
Profil
Dominique P.
Monnet is currently a Director at PDL BioPharma, Inc., a Director at Noden Pharma DAC, and the President & Director at Noden Pharma USA, Inc. Previously, he was a Director at Evofem Biosciences, Inc. in 2019, a Managing Director at Biotech Advisors International LLC from 2013 to 2014, and the General Manager at ALZA Corp.
He also served as the Vice President & GM-Inflammation Business Unit at Amgen, Inc. from 2011 to 2013.
Additionally, he was the General Manager at Ciba-Geigy Corp., the Chief Marketing Officer & Senior Vice President at Alexion Pharmaceuticals, Inc. from 2014 to 2015, and the General Manager at Schering-Plough International, Inc. Mr. Monnet holds an MBA from INSEAD and an undergraduate degree from École des Hautes Études Commerciales du Nord.
Postes actifs de Dominique Monnet
| Sociétés | Poste | Début |
|---|---|---|
| PDL BIOPHARMA, INC. | Director/Board Member | 31/12/2018 |
Noden Pharma DAC
 Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | Director/Board Member | - |
Noden Pharma USA, Inc.
 Noden Pharma USA, Inc. Electronic Equipment/InstrumentsElectronic Technology Noden Pharma USA, Inc. is engaged in manufacturing and commercialization of filled and finished medicine products. The company is headquartered in Orlando, FL. | President | - |
Anciens postes connus de Dominique Monnet
| Sociétés | Poste | Fin |
|---|---|---|
| EVOFEM BIOSCIENCES, INC. | Director/Board Member | 13/12/2019 |
| ALEXION PHARMACEUTICALS, INC. | Sales & Marketing | 01/10/2015 |
| Biotech Advisors International LLC | Chief Executive Officer | 01/05/2014 |
| AMGEN INC. | Corporate Officer/Principal | 01/07/2013 |
| ALZA CORPORATION | Corporate Officer/Principal | - |
Formation de Dominique Monnet
| INSEAD | Masters Business Admin |
| École des Hautes Études Commerciales du Nord | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| EVOFEM BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
| Ciba-Geigy Corp. | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
Noden Pharma DAC
Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | Health Technology |
Noden Pharma USA, Inc.
Noden Pharma USA, Inc. Electronic Equipment/InstrumentsElectronic Technology Noden Pharma USA, Inc. is engaged in manufacturing and commercialization of filled and finished medicine products. The company is headquartered in Orlando, FL. | Electronic Technology |
| Biotech Advisors International LLC | |
Schering-Plough International, Inc.
 Schering-Plough International, Inc. Pharmaceuticals: MajorHealth Technology Schering-Plough International, Inc. is a private company that manufactures and sells pharmaceuticals and health care products. The company is based in New Jersey, DE. | Health Technology |
